Περιεχόμενα
Section I. Mature B-Cell and Plasma Cell Neoplasms
1. B-Cells: normal maturation and strategies in identification of abnormal cells Wei Wang
2. Chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma Wei Wang
3. Follicular lymphoma Wei Wang
4. Low-grade b-cell lymphomas with plasmacytic differentiation Andres E Quesada and Pei Lin
5. Splenic b-cell lymphoma/leukemia (other than splenic marginal zone lymphoma) and b-cell prolymphocytic leukemia Beenu Thakral and Sa A Wang
6. Aggressive b-cell lymphomas Shaoying Li, Jie Xu and Lianqun Qiu
7. Large b-cell lymphoma with plasmablastic differentiation Lianqun Qiu, Shaoying Lin, Pei Lin, Jiehao Zhou, Yi Zhou and Jie Xu
8. Plasma cell neoplasms Andres E Quesada and Pei Lin
Section II. Mature T-Cell and Nk-Cell Neoplasms
9. T and NK cells: normal maturation and strategies in identification of abnormal cells Wei Wang
10. T-cell large granular lympocytic leukemia Min Shi, Michael M. Timm and Dragan Jevremovic
11. Hepatosplenic T-cell lymphoma Min Shi, Michael M. Timm and Dragan Jevremovic
12. Adult T-cell leukemia/lymphoma Hong Fang and Wei Wang
13. T-prolymphocytic leukemia Hong Fang and Wei Wang
14. Mycosis fungoides/ Sezary syndrome Hong Fang and Wei Wang
15. NK-Large granular lympocytic leukemia Min Shi, Michael M. Timm and Dragan Jevremovic
16. Aggressive NK-cell leukemia Min Shi, Michael M. Timm and Dragan Jevremovic
17. Nodal T follicular helper cell lymphoma Chi Young Ok, Francisco Vega and Sa A. Wang
18. Anaplastic large cell lymphoma, ALK-positive Jie Xu, Shaoying Li and L. Jeffrey Medeiros
19. Anaplastic large cell lymphoma, ALK-negative Jie Xu, Jeffrey Medeiros and Shaoying Li
20. Other nodal and extranodal mature T/NK-cell lymphomas Chi Young Ok, Francisco Vega and Sa A. Wang
Section III. Acute Lymphoblastic Leukemia/Lymphoma
21. B-lymphopblastic leukemia/lymphoma Sa A. Wang
22. T-lymphopblastic leukemia/lymphoma Sa A. Wang
Section IV. Acute Myeloid Leukemia
23. Acute myeloid leukemia: introduction Wei Wang
24. Acute myeloid leukemia with RUNX1: RUNX1T1 fusion Wei Wang
25. Acute myeloid leukemia with CBFB rearrangement Wei Wang
26. Acute promyelocytic leukemia Hong Fang and Wei Wang
27. Acute myeloid leukemia with NPM1 mutation Wei Wang
28. Acute myeloid leukemia with KMT2A rearrangement Wei Wang
29. Acute myeloid leukemia with MECOM rearrangement Wei Wang
30. Acute myeloid leukemia with DEK: NUP214 fusion Wei Wang
31. Acute myeloid leukemia with NUP98 rearrangement Mahsa Khanlari and Wei Wang
32. Acute myeloid leukemia with mutated TP53 Fnu Sameeta and Wei Wang
33. Acute erythroid leukemia Wei Wang
34. Acute megakaryoblastic leukemia Mahsa Khanlari and Wei Wang
35. Normal myelomonocytic maturation and evaluation of acute myeloid leukemia minimal/measurable residual disease Wei Wang and Sa A. Wang
Section V. Acute Leukemias of Mixed or Ambiguous Lineage
36. Acute undifferentiated leukemia Vasiliki Leventaki and Sa A. Wang
37. Mixed-phenotype acute leukemia Vasiliki Leventaki and Sa A Wang
Section VI. Neoplastic Plasmacytoid Dendritic Cell Proliferation
38. Plasmacytoid dendritic cells: from normal maturation to neoplastic proliferations Wei Wang
Section VII. Other Myeloid Neoplasms and Bone Marrow Failure Diseases
39. Chronic myeloid neoplasms and bone marrow failure disorders Sanam Loghavi, Sa A. Wang and Wei Wang
40. Systemic mastocytosis Wei Wang, Jie Xu, Sa A. Wang, Lianqun Qiu and Shaoying Li
Section VIII. Flow Cytometry Data Handling
41. Flow cytometry data processing, analysis, artifacts and pitfalls Xuehai Wang
Section IX. Chimeric Antigen Receptor (Car) T-Cell
42. Chimeric antigen receptor (CAR) T-Cell immunotherapy and flow cytometric monitoring of CAR T-cells Jianhua Ling and Sa A. Wang
Appendix: common flow cytometry markers and their utility.